The Centers for Medicare and Medicaid Services has signaled it will build a more consistent payment structure for clinical software and AI that factors in their impact on patient outcomes. In proposed rules for hospital outpatient payments and physician fees for 2027, CMS outlined an interim step that revamps how it labels and pays for several clinical AI services.
For years, Medicare has struggled with pricing algorithms and AI tools, having systems built for physical items like CT scanner wear but not for software that predicts cardiac risk from a scan or maps prostate cancer spread. The new approach aims to close that gap by tying reimbursement to measurable patient outcomes.
The proposal is the third installment in STAT’s “Paying for AI” series, which has examined how AI tools influence healthcare affordability. CMS is starting with practical label and payment changes for 2027 while hinting at broader structural shifts ahead. Industry stakeholders now have a comment period before final rules take effect.
The move could reshape the business case for clinical AI adoption across US hospitals and clinics by creating a clearer financial pathway for hospitals deploying these tools.
